Cancer Incidence And Mortality in China,2006

来源 :Chinese Journal of Cancer Research | 被引量 : 0次 | 上传用户:warinkeng
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Objective:To describe the cancer incidence and mortality rates in 2006 and evaluate the cancer burden in China.Methods:Cancer registration data in 2006 from 34 cancer registries were collected,evaluated and pooled to calculate cancer incidence and mortality rates.The data analyses included mortality to incidence ratio(MI),morphological verification percentage(MV%) and proportion of death certification only(DCO%).Cumulative incidence and mortality rates were calculated using crude data,age-standardized data,and specific data for cancer site,age,sex and area(urban or rural).Results:In 2006,34 registries with qualified registration data covered a total population of 59,567,322(46,558,108 in urban areas and 13,009,214 in rural areas).The crude and age-standardized cancer incidence rates were 273.66 per 100,000 and 190.54 per 100,000,respectively.The crude and age-standardized cancer mortality rates were 175.70 per 100,000 and 117.67 per 100,000,respectively.Cancers of lung,stomach,colon and rectum,liver,and breast in female were the five most common forms of cancer in China,which accounted for 58.99% of all new cancer cases.Lung cancer was the leading cause of cancer death,followed by stomach cancer,liver cancer,esophageal cancer and colorectal cancer.Conclusion:Cancer is still an important public health issue in China with an increasing disease burden.Specifically,the incidence rates for lung cancer,colorectal cancer and breast cancer were increasing,but those for stomach cancer and esophageal cancer were decreasing.However,age-specific incidence rate remained stable,indicating that the aging population was the major source of the increasing cancer burden. Objective: To describe the cancer incidence and mortality rates in 2006 and evaluate the cancer burden in China. Methods: Cancer registration data in 2006 from 34 cancer registries were collected, evaluated and pooled to calculate cancer incidence and mortality rates. The data analyzes included mortality to incidence ratio (MI), morphological verification percentage (MV%) and proportion of death certification only (DCO%). Cumulative incidence and mortality rates were calculated using crude data, age-standardized data, and specific data for cancer site, age, Results of In 2006, 34 registries with qualified registration data covered a total population of 59,567,322 (46,558,108 in urban areas and 13,009,214 in rural areas). The crude and age-standardized cancer incidence rates were 273.66 per 100,000 and 190.54 per 100,000, respectively. The crude and age-standardized cancer mortality rates were 175.70 per 100,000 and 117.67 per 100,000, respectively. Cancer of lung, stomach, colon an d rectum, liver, and breast in female were the five most common forms of cancer in China, which accounted for 58.99% of all new cancer cases. Lung cancer was the leading cause of cancer death, followed by stomach cancer, liver cancer, esophageal cancer and still colorectal cancer.Conclusion: Cancer is still an important public health issue in China with an increasing disease burden.Specifically, the incidence rates for lung cancer, colorectal cancer and breast cancer were increasing, but those for stomach cancer and esophageal cancer were decreasing .However, age-specific incidence rate remained stable, indicating that the aging population was the major source of the increasing cancer burden.
其他文献
AIM:To investigate three isoforms of survivin in colorectal adenocarcinomas.METHODS:We used the LightCycler Technology(Roche),along with a common forward primer
目的:研究冠心病患者行阿托伐他汀+曲美他嗪治疗的效果.方法:选择我院2018.5-2019.5收治的120例冠心病患者,采纳“用药差异性”随机分为观察组(阿托伐他汀+曲美他嗪)与对照组
目的:将颈腰康胶囊与双氯芬酸钠应用于腰椎间盘突出症患者的临床治疗中,并对其治疗效果以及对患者腰椎功能产生的影响进行分析.方法:将200例于我院接受治疗的腰椎间盘突出症
目的:分析盐酸贝那普利联合氨氯地平治疗高血压合并冠心病疗效及安全性.方法:选择2017年1月-2019年12月期间我院收治的高血压合并冠心病患者700例为研究对象,随机分成观察组(
目的:前列地尔联合肾康注射液治疗慢性肾衰竭的疗效分析.方法:择取我院自2018年3月-2019年8月收治的82例慢性肾衰竭患者作为研究对象,随机分为对照组、研究组,每组各41例.对
目的:分析在浆细胞性乳腺炎患者中应用常规治疗联合小金片的临床价值.方法:本文依据随机数字方法将本院选自2018年5月-2020年8月期间诊治的90例浆细胞性乳腺炎患者进行比对,
目的:探究加味涤痰汤联合针刺疗法治疗急性缺血性脑卒中的临床疗效.方法:随机选取2018年4月到2020年4月我院100例急性脑卒中患者,给予对照组常规西药治疗,实验组除给予常规药
目的:对比分析不同手术方案用于股骨粗隆间骨折治疗临床效果.方法:选取我院股骨粗隆间骨折患者50(2016年8月至2018年8月),随机分为股骨近端防旋髓内钉治疗的观察组(25例)与锁
专利号:WO2013133860(A3)专利名称:METHOD AND ASSEMBLY FOR CONVEYING WELL LOGGING TOOLS申请号:WO2012US44540申请日:2012.06.28专利申请人:HALLIBURTON ENERGY SERVICES,
目的:探究老年糖尿病合并肺炎采用氨溴索联合抗菌药物治疗的临床疗效.方法:将2017年3月~2019年12月在我院接受治疗的112例老年糖尿病合并肺炎患者作为研究对象,以随机数字表法